Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma

Asma Begum, Issei Imoto, Ken ichi Kozaki, Hitoshi Tsuda, Emina Suzuki, Teruo Amagasa, Johji Inazawa

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Amplification of chromosomal DNA is thought to be one of the mechanisms activating cancer-related genes in tumors. To identify the most likely target for amplification in the region 19q13.12-q13.2, detected previously in SKN-3 cells by a genome-wide screening of DNA copy-number aberrations in a panel of oral squamous-cell carcinoma (OSCC) cell lines, we determined the extent of the amplicon, analyzed a panel of cell lines for the expression of candidate genes within the amplicon, and then evaluated growth-suppressive effects by knocking down genes of interest. Reported information about the function and/or expression of each gene, remarkable overexpression in SKN-3 cells and relatively frequent overexpression in additional OSCC lines compared with an immortalized normal oral epithelial cell line, and expression level-dependent proliferation-promoting activity led us to conclude that the p21-activated kinase 4 (PAK4) gene was the most likely target. An immunohistochemical analysis of primary tumors from 105 cases of head and neck SCC including 50 cases of OSCC demonstrated the overexpression of PAK4 to be significantly associated with a poorer prognosis. These findings reveal that the PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of OSCC cells, and that PAK4 might be a good diagnostic and/or therapeutic target. (Cancer Sci 2009; 100: 1908-1916).

Original languageEnglish
Pages (from-to)1908-1916
Number of pages9
JournalCancer Science
Volume100
Issue number10
DOIs
Publication statusPublished - Oct 2009
Externally publishedYes

Fingerprint

p21-Activated Kinases
Gene Amplification
Squamous Cell Carcinoma
Cell Line
Gene Expression
Neoplasms
Neoplasm Genes
DNA
Genes
Neck
Epithelial Cells
Head
Genome
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. / Begum, Asma; Imoto, Issei; Kozaki, Ken ichi; Tsuda, Hitoshi; Suzuki, Emina; Amagasa, Teruo; Inazawa, Johji.

In: Cancer Science, Vol. 100, No. 10, 10.2009, p. 1908-1916.

Research output: Contribution to journalArticle

Begum, A, Imoto, I, Kozaki, KI, Tsuda, H, Suzuki, E, Amagasa, T & Inazawa, J 2009, 'Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma', Cancer Science, vol. 100, no. 10, pp. 1908-1916. https://doi.org/10.1111/j.1349-7006.2009.01252.x
Begum, Asma ; Imoto, Issei ; Kozaki, Ken ichi ; Tsuda, Hitoshi ; Suzuki, Emina ; Amagasa, Teruo ; Inazawa, Johji. / Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. In: Cancer Science. 2009 ; Vol. 100, No. 10. pp. 1908-1916.
@article{2bfbbfad44114f6f87442cce08f695d4,
title = "Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma",
abstract = "Amplification of chromosomal DNA is thought to be one of the mechanisms activating cancer-related genes in tumors. To identify the most likely target for amplification in the region 19q13.12-q13.2, detected previously in SKN-3 cells by a genome-wide screening of DNA copy-number aberrations in a panel of oral squamous-cell carcinoma (OSCC) cell lines, we determined the extent of the amplicon, analyzed a panel of cell lines for the expression of candidate genes within the amplicon, and then evaluated growth-suppressive effects by knocking down genes of interest. Reported information about the function and/or expression of each gene, remarkable overexpression in SKN-3 cells and relatively frequent overexpression in additional OSCC lines compared with an immortalized normal oral epithelial cell line, and expression level-dependent proliferation-promoting activity led us to conclude that the p21-activated kinase 4 (PAK4) gene was the most likely target. An immunohistochemical analysis of primary tumors from 105 cases of head and neck SCC including 50 cases of OSCC demonstrated the overexpression of PAK4 to be significantly associated with a poorer prognosis. These findings reveal that the PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of OSCC cells, and that PAK4 might be a good diagnostic and/or therapeutic target. (Cancer Sci 2009; 100: 1908-1916).",
author = "Asma Begum and Issei Imoto and Kozaki, {Ken ichi} and Hitoshi Tsuda and Emina Suzuki and Teruo Amagasa and Johji Inazawa",
year = "2009",
month = "10",
doi = "10.1111/j.1349-7006.2009.01252.x",
language = "English",
volume = "100",
pages = "1908--1916",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma

AU - Begum, Asma

AU - Imoto, Issei

AU - Kozaki, Ken ichi

AU - Tsuda, Hitoshi

AU - Suzuki, Emina

AU - Amagasa, Teruo

AU - Inazawa, Johji

PY - 2009/10

Y1 - 2009/10

N2 - Amplification of chromosomal DNA is thought to be one of the mechanisms activating cancer-related genes in tumors. To identify the most likely target for amplification in the region 19q13.12-q13.2, detected previously in SKN-3 cells by a genome-wide screening of DNA copy-number aberrations in a panel of oral squamous-cell carcinoma (OSCC) cell lines, we determined the extent of the amplicon, analyzed a panel of cell lines for the expression of candidate genes within the amplicon, and then evaluated growth-suppressive effects by knocking down genes of interest. Reported information about the function and/or expression of each gene, remarkable overexpression in SKN-3 cells and relatively frequent overexpression in additional OSCC lines compared with an immortalized normal oral epithelial cell line, and expression level-dependent proliferation-promoting activity led us to conclude that the p21-activated kinase 4 (PAK4) gene was the most likely target. An immunohistochemical analysis of primary tumors from 105 cases of head and neck SCC including 50 cases of OSCC demonstrated the overexpression of PAK4 to be significantly associated with a poorer prognosis. These findings reveal that the PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of OSCC cells, and that PAK4 might be a good diagnostic and/or therapeutic target. (Cancer Sci 2009; 100: 1908-1916).

AB - Amplification of chromosomal DNA is thought to be one of the mechanisms activating cancer-related genes in tumors. To identify the most likely target for amplification in the region 19q13.12-q13.2, detected previously in SKN-3 cells by a genome-wide screening of DNA copy-number aberrations in a panel of oral squamous-cell carcinoma (OSCC) cell lines, we determined the extent of the amplicon, analyzed a panel of cell lines for the expression of candidate genes within the amplicon, and then evaluated growth-suppressive effects by knocking down genes of interest. Reported information about the function and/or expression of each gene, remarkable overexpression in SKN-3 cells and relatively frequent overexpression in additional OSCC lines compared with an immortalized normal oral epithelial cell line, and expression level-dependent proliferation-promoting activity led us to conclude that the p21-activated kinase 4 (PAK4) gene was the most likely target. An immunohistochemical analysis of primary tumors from 105 cases of head and neck SCC including 50 cases of OSCC demonstrated the overexpression of PAK4 to be significantly associated with a poorer prognosis. These findings reveal that the PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of OSCC cells, and that PAK4 might be a good diagnostic and/or therapeutic target. (Cancer Sci 2009; 100: 1908-1916).

UR - http://www.scopus.com/inward/record.url?scp=70349591634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349591634&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2009.01252.x

DO - 10.1111/j.1349-7006.2009.01252.x

M3 - Article

VL - 100

SP - 1908

EP - 1916

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 10

ER -